ISOMORPHIC LABS
LIVE

Serial Number

97170031

Owner

Isomorphic Labs Limited

Attorney

Cynthia Johnson Walden

Filing Date

Dec 13, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ISOMORPHIC LABS Trademark

Serial Number: 97170031 • Registration: 7781596

ISOMORPHIC LABS is a trademark filed by Isomorphic Labs Limited on December 13, 2021. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Isomorphic Labs Limited (13 trademarks)

280 Bishopsgate
London EC2M4RB , GB

Entity Type: 99

Trademark Details

Filing Date

December 13, 2021

Registration Date

May 6, 2025

Published for Opposition

March 18, 2025

Goods & Services

Downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for predicting protein structure, discovering pharmaceutical drugs, and developing pharmaceutical products; downloadable computer software, computer programs and computer software algorithms for manipulating received or inputted data generated in a virtual space in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, and predictive assistance technologies for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development

Software as a service (SAAS) services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning technologies for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; providing online, non-downloadable computer software platforms using artificial intelligence, machine earning, deep learning, and reinforcement learning for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; testing of computing methods, computer software algorithms, computer software, and computer hardware for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; scientific, pharmaceutical, and medical research; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; medical, pharmaceutical, and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific research in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research, all for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer aided data analysis for scientific research purposes in the fields of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, data tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, chemistry, physics, biology, all for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer modelling services; scientific services for the analysis of organic compounds; drug discovery services

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 14, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 14, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 14, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 14, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 14, 2025 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 6, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
May 6, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 18, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 18, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 12, 2025 NONP
NOTICE OF ALLOWANCE CANCELLED
Jan 30, 2025 IUCN
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jan 27, 2025 JURT
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Jan 27, 2025 PCBG
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 11, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jan 11, 2025 EX2G
ASSIGNED TO PETITION STAFF
Jan 6, 2025 APET
TEAS PETITION TO AMEND BASIS RECEIVED
Nov 20, 2024 TPAD
SOU EXTENSION 2 FILED
Nov 19, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 19, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 18, 2024 EXRA
SOU EXTENSION 1 GRANTED
May 17, 2024 EX1G
SOU EXTENSION 1 FILED
May 17, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
May 17, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 19, 2024 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 19, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 19, 2024 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 21, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 26, 2023 NPUB
PUBLISHED FOR OPPOSITION
Sep 26, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 6, 2023 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Aug 21, 2023 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Aug 18, 2023 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 14, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 14, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 14, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 14, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 14, 2023 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
May 25, 2023 GNFN
FINAL REFUSAL E-MAILED
May 25, 2023 GNFR
FINAL REFUSAL WRITTEN
May 25, 2023 CNFR
ASSIGNED TO EXAMINER
May 3, 2023 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 22, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 21, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 21, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 21, 2022 GNRN
NON-FINAL ACTION E-MAILED
Sep 21, 2022 GNRT
NON-FINAL ACTION WRITTEN
Sep 21, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 20, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 17, 2021 NWOS
NEW APPLICATION ENTERED
Dec 16, 2021 NWAP